BioMarin Pharmaceuticals BMRN Rest of world — Total long-lived assets

Similar metrics at other companies

UTHRRest-of-World — Total long-lived assets

$15.8M+35.0%

SNAPRest Of World — Total long-lived assets

$133.16M-1.3%

QLYSRest of world — Total long-lived assets

$1.96M-9.8%

RELYRest of world — Total long-lived assets

$16.45M+45.2%

SKINRest of World — Total long-lived assets

$600K-50.7%

CXTRest of the World — Total long-lived assets

$18.4M+12.9%

FAQ

What is BioMarin Pharmaceuticals's rest of world — total long-lived assets?

BioMarin Pharmaceuticals (BMRN) reported rest of world — total long-lived assets of $20.84M in Q4 2025.

How has BioMarin Pharmaceuticals's rest of world — total long-lived assets changed year-over-year?

BioMarin Pharmaceuticals's rest of world — total long-lived assets increased by 53.2% year-over-year, from $13.6M to $20.84M.

What does rest of world — total long-lived assets mean?

This metric represents the total book value of non-current, tangible, and intangible assets held by the company in geographic regions outside of its primary reporting markets. It reflects the capital investment in infrastructure, manufacturing facilities, or intellectual property rights localized to these specific international territories. Monitoring this helps assess the company's physical and operational footprint in emerging or secondary global markets.